DIHYDROGENATED ALKALOIDS OF ERGOT IN THE INVESTIGATION AND TREATMENT OF DIASTOLIC HYPERTENSION
Open Access
- 1 January 1952
- Vol. 14 (1) , 77-86
- https://doi.org/10.1136/hrt.14.1.77
Abstract
17 patients were treated and the effects observed over a period of at least 6 mos. in 12 cases, 4 mos. in 4 cases and 3 mos. in the other. 16 of the subjects had benign hypertension and 1 had malignant essential hypertension. Hydergine, an adrenergic blocking drug, was given intraven. at 1st and later by mouth and intramusc. injn. for a period of 14 days. 13 cases were relieved or improved. The fall in blood pressure was 2-66 mm. Hg systolic and 6-40 mm. Hg diastolic. Hydergine acts by its adrenergic blockade and possibly by its central nervous depression. The over-all blood pressure reduction was moderate. No final conclusions were made.Keywords
This publication has 8 references indexed in Scilit:
- Effect of orally administered dihydroergocornine (D.H.O. 180) on hypertensionThe American Journal of Medicine, 1950
- THE RESULTS OF MEDICAL AND SURGICAL TREATMENT OF ESSENTIAL HYPERTENSIONHeart, 1949
- ESSENTIAL HYPERTENSIONJAMA, 1949
- THE EFFECTS OF CERTAIN DIHYDROGENATED ALKALOIDS OF ERGOT IN HYPERTENSIVE PATIENTSThe Lancet Healthy Longevity, 1948
- Die Dihydroderivate der natürlichen linksdrehenden Mutterkornalkaloide. (9. Mitteilung über Mutterkornalkaloide)Helvetica Chimica Acta, 1943
- Die Alkaloide der Ergotoxingruppe: Ergocristin, Ergokryptin und Ergocornin. (7. Mitteilung über Mutterkornalkaloide)Helvetica Chimica Acta, 1943
- DIFFUSE ARTERIOLAR DISEASE WITH HYPERTENSION AND THE ASSOCIATED RETINAL LESIONSMedicine, 1939
- On some physiological actions of ergotThe Journal of Physiology, 1906